A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries

por Humbert, Maria Victoria, Opurum, Precious Chinonyerem, Brendish, Nathan J, Poole, Stephen, He, Peijun, Katis, Ioannis, Quaye, Jerry, Bediako, Yaw, Duriez, Patrick Jacques, Eason, Robert W, Sones, Collin, Quaye, Osbourne, Awandare, Gordon A, Christodoulides, Myron, Clark, Tristan W, Quashie, Peter K, McCormick, Christopher J
Publicado 2021